Related Experiment Videos
Sentinel node biopsy in breast cancer.
1Department of Surgery, University Central Hospital, Helsinki, Finland.
Acta Oncologica (Stockholm, Sweden)
|December 28, 1999
Summary
Sentinel node biopsy for breast cancer identifies key lymph nodes. This method, using dye or radioactive tracers, accurately predicts the status of other nodes, aiding treatment decisions.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Breast cancer metastasis often involves initial lymphatic spread to sentinel lymph nodes.
- Sentinel node biopsy (SNB) aims to assess the status of these initial nodes to predict overall lymphatic involvement.
Purpose of the Study:
- To evaluate the feasibility and accuracy of sentinel node biopsy in breast cancer staging.
- To determine the reliability of sentinel node status in predicting axillary lymph node involvement.
Main Methods:
- Injection of blue dye or radioactive tracer around the breast tumor to identify the sentinel node.
- Localization assistance through scintigraphy.
- Comparison of sentinel node status with axillary lymph node dissection findings.
Main Results:
- Reported detection rates for sentinel nodes range from 66% to 100%.
- Reported false-negative rates vary significantly, from 0% to 17%.
- Theoretical acceptable false-negative risk rate is calculated at 2-3%.
Conclusions:
- Sentinel node biopsy is a feasible method for staging breast cancer lymphatic metastasis.
- Further consensus on acceptable false-negative rates and practical validation are needed for widespread clinical adoption.
- A theoretical false-negative rate of 2-3% is considered acceptable.